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From Friday 13th to Sunday 15th October 
this year, the inaugural meeting of the 
Hepato-Pancreatico-Biliary Association of 
South African (HPBASA) was held in the 
Sandton Convention Centre. Organised by 
Professor Martin Smith and Dr Jose Ramos 
on behalf of the founding committee, this 
meeting was decidedly not dominated by any 
group, but was rather specifically meant as a 
multidisciplinary gathering of those inter-
ested in liver and pancreatic disease.
Radiology was represented by a number 
of our group, as were radiation oncologists, 
nuclear medicine physicians, surgeons, phy-
sicians, anaesthetists, the medical funders 
and the ultimate arbiters, the pathologists. 
Regrettably, one of the liver pathology pio-
neers, Professor Pauline Hall, was unable to 
be present.
A number of interesting sessions included 
discussions on non-alcoholic fatty liver dis-
ease (NAFLD) and non-alcoholic steato-
hepatitis (NASH), and the importance in 
suspecting this condition, particularly before 
liver resection. Overt steatosis can compro-
mise the residual liver postoperatively, lead-
ing to potentially fatal acute liver failure.
Liver biopsy and the current role of cytol-
ogy were also discussed, with some of the 
controversy around tumour seeding of the 
biopsy track debated.
Recurrent acute idiopathic pancreatitis 
and its investigation came under scrutiny, 
with the role of endoscopic ultrasound (EUS) 
and microlithiasis highlighted.
Pancreatic cancer was also examined, 
including the various chemotherapy and 
radiotherapy options, but there remains little 
positive in this condition.
Liver tumours were broadly discussed, 
and in particular the role that gadobenate in 
MRI has in resolving focal nodular hyper-
plasia (FNH) versus adenoma was presented 
by Martin Haagensen. The thorny issue of an 
FNH without a scar versus well-differenti-
ated hepatocellular carcinoma (HCC) could 
possibly be resolved by this agent, using the 
delayed scans to prove biliary excretion and 
therefore presumably a functional drainage 
system. The potential for delayed excretion 
by the nodular-type cholangiocarcinoma 
(and possibly HCC) would need to be con-
sidered, however.
Therapeutic intervention for HPB malig-
nancy, including cholangiocarcinoma 
and metastases, was presented by Charles 
Sanyika. A clear overview of the radiologi-
cal options in tumor oncology was given, 
with the relative values of radiofrequency 
ablation, percutaneous ethanol injection 
and chemoembolisation debated. The role 
of radioactive yttrium also has some sup-
porters. The differences in behaviour of the 
‘African’ versus ‘Asian’ types of HCC still has 
no clear resolution, but may account for the 
variation in reported efficacy of chemoem-
bolisation.
EUS is very much the up-and-coming 
modality, with a number of pivotal roles sup-
ported for this technology, but the difficulty 
in learning the ultrasound component was 
emphasised.
A thought-provoking presentation on 
conscious sedation focussed on the dangers 
of over-sedation for procedures.
Pancreatic and liver cysts were covered, 
including management of the increasingly 
diagnosed intraductal papillary mucinous 
neoplasm (IPMN - previously also called 
ductectatic mucinous adenocarcinoma). 
Mucinous cystic neoplasms generally 
were also addressed by Professor Christos 
Dervenis from Greece. IPMN, in particular, 
has experienced a similar rise from obscurity 
that has been seen with gastrointestinal stro-
mal tumours (GISTs) - the recent upsurge 
of IPMN has reportedly been labelled ‘a 
plague’.
Fibro-polycystic liver disease (liver or duc-
tal plate malformations) was very well pack-
aged by Prof Alan Paterson from Wits, who 
drew the audience’s attention to a seminal 
article by Desmet1 attempting to link togeth-
er the confusing and apparently discrete enti-
ties of the polycystic liver diseases, Caroli’s 
(both the disease and the syndrome - did you 
know they were different?), plus those little 
nuisances better known to pathologists, the 
von Meyenburg complexes. In essence the 
proposal is that there is either an ectatic or an 
involutional (or necroinflammatory) process 
that affects the development of the ductal 
plate system at various levels of branching. 
(The ductal plate is an embryological sleeve 
of periportal tissue that goes on to become 
the biliary tree). Varying degrees of associ-
ated fibrosis occur in either process.
It is broken down thus: 
A useful pictorial review covering the 
same theme has recently appeared in 
Radiographics.2
The Johannesburg transplantation group’s 
activities were thoroughly covered, empha-
sising some of the particular local finan-
cial, political, and ethical issues around 
liver transplants. The present status of their 
pancreatic transplantation programme was 
also covered, detailing the move away from 
the use of the pancreatic duct-to-bladder 
implant to gut implantation. Intrahepatic 
islet cell transplants (injected into the portal 
vein), the delegates were told, had not shown 
good long-term results so far. Also, a number 
of donor pancreases are required to harvest 
cells for a single patient.
Thrombosis and portal hypertension were 
also covered from medical, radiological and 
surgical perspectives. The transjugular intra-
heptic stent (TIPS) technique has largely 
moved shunting activity away from surgery, 
but there was a strong view expressed that 
surgical shunting may need to be dusted 
off and re-introduced. Covered TIPS stents 
appear to offer the promise of longer patency, 
but there is also work at reducing flow in 
patients with TIPS who develop problematic 
hepatic encephalopathy (which can be devas-
tating to personal function).
All in all, this was a very useful forum to 
gain in-depth insights into the way the other 
members of a team address the diseases 
affecting a particular group of organs. There 
was strong support for making this an annual 
gathering, and again, with the specific intent 
of making it as inclusive as possible.
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Table I
Biliary branches Ectasia Necroinflammatory
Small  Autosomal-  von Meyenburg 
 dominant  complexes/  
 polycystic kidney  ‘microhamarto- 
 disease (ADPKD) mas’ 
 (the old adult type) 
Medium size Autosomal-  Congenital hepatic 
 recessive polycystic  fibrosis (CHF) 
 kidney disease 
 (ARPKD) (the  
 old infantile type) 
Central/large  Caroli's disease Caroli's syndrome 
ducts   (= Caroli's disease 
plus CHF)
Extrahepatic Choledochal cyst  Extrahepatic biliary 
atresia
       
